Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 11, Pages e1544-e1544
Publisher
Springer Nature
Online
2014-11-27
DOI
10.1038/cddis.2014.510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dehydroascorbic acid taken up by glucose transporters stimulates estradiol production through inhibition of JNK/c-Jun/AP1 signaling in JAR cells
- (2014) Yongjie Wang et al. MOLECULAR HUMAN REPRODUCTION
- WNT7B Promotes Bone Formation in part through mTORC1
- (2014) Jianquan Chen et al. PLoS Genetics
- Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters
- (2013) Gretl Hendrickx et al. BONE
- Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/ -Catenin Signaling
- (2013) N. Li et al. MOLECULAR CANCER THERAPEUTICS
- WNT signaling in bone homeostasis and disease: from human mutations to treatments
- (2013) Roland Baron et al. NATURE MEDICINE
- Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
- (2013) Ernesto Canalis Nature Reviews Endocrinology
- Ascorbic Acid Uptaken by Sodium-Dependent Vitamin C Transporter 2 Induces βhCG Expression through Sp1 and TFAP2A Transcription Factors in Human Choriocarcinoma Cells
- (2012) Lihua Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Secreted and Transmembrane Wnt Inhibitors and Activators
- (2012) C.-M. Cruciat et al. Cold Spring Harbor Perspectives in Biology
- Alternative Wnt Pathways and Receptors
- (2012) R. van Amerongen Cold Spring Harbor Perspectives in Biology
- Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension
- (2012) Dioma U. Udeoji et al. Therapeutic Advances in Respiratory Disease
- Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/ -Catenin-Mediated Transcription in Human Breast Tumor Cells
- (2011) H. N. Tinsley et al. Cancer Prevention Research
- Genetic Ablation of cGMP-Dependent Protein Kinase Type I Causes Liver Inflammation and Fasting Hyperglycemia
- (2011) S. Z. Lutz et al. DIABETES
- Colon Tumor Cell Growth-Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition
- (2010) H. N. Tinsley et al. Cancer Prevention Research
- An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction
- (2010) Victor Palit et al. Nature Reviews Urology
- cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
- (2010) S. H. Francis et al. PHARMACOLOGICAL REVIEWS
- A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle
- (2009) J. E. Koltes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sfrp Controls Apicobasal Polarity and Oriented Cell Division in Developing Gut Epithelium
- (2009) Makoto Matsuyama et al. PLoS Genetics
- Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling
- (2008) Ximei Wu et al. CELL
- Phosphorylation of GSK-3β by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes
- (2008) Yosuke Kawasaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation
- (2008) Matthew J Hilton et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started